课题基金 / 基金详情

Cellular cross-talk between liver progenitor cells and hepatic stellate cells is required for hepatic fibrogenesis

Cellular cross-talk between liver progenitor cells and hepatic stellate cells is required for hepatic fibrogenesis
肝祖细胞和肝星状细胞之间的细胞串扰是肝纤维发生所必需的
批准号:
nhmrc : 1087125
负责人:
Dr Janina Tirnitz-Parker
金额:
$41.24万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2015
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2015-01-01 至 2018-12-31

项目摘要

项目成果

Dr Janina Tirnitz-Parker的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Deloitte Access Economics data proposes the total economic burden of liver disease in Australia in 2012 was >$50 billion. This study will identify how the liver heals itself by inducing liver cell populations which interact to regenerate damaged liver tissue in chronic liver disease. This knowledge may lead to the development of novel therapeutic interventions for the treatment of liver scarring and liver cancer, and to assist in normal liver regeneration following chronic liver disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cellular cross-talk between liver progenitor cells and hepatic stellate cells is required for hepatic fibrogenesis
  • 批准号:
    nhmrc : GNT1087125
  • 项目类别:
    Project Grants
  • 资助金额:
    $59.92万
  • 财政年份:
    2015
  • 负责人:
    Dr Janina Tirnitz-Parker
  • 依托单位:
Role of hepatic stellate cell and liver progenitor cell interactions in the regulation of wound healing and liver regeneration
  • 批准号:
    nhmrc : 1031330
  • 项目类别:
    Project Grants
  • 资助金额:
    $41.39万
  • 财政年份:
    2012
  • 负责人:
    Dr Janina Tirnitz-Parker
  • 依托单位:
国内基金
海外基金
基于NLRP3炎性小体与自噬Cross-talk探讨心康冲剂干预心肌纤维化的机制研究
PKM2琥珀酰化修饰介导癌细胞与血小板间Cross-talk调控胆管癌侵袭转移的研究
  • 批准号:
    JCZRYB202500379
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
三痹汤激活线粒体自噬影响免疫细胞Cross talk延缓椎间盘退变的机制研究